Pu, Y., Yin, H., Dong, C., Xiang, H., Wu, W., Zhou, B., . . . Xu, H. (2021). Sono‐Controllable and ROS‐Sensitive CRISPR‐Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy. Advanced materials (Weinheim), 33(45), e2104641-n/a. https://doi.org/10.1002/adma.202104641
Chicago-Zitierstil (17. Ausg.)Pu, Yinying, Haohao Yin, Caihong Dong, Huijing Xiang, Wencheng Wu, Bangguo Zhou, Dou Du, Yu Chen, und Huixiong Xu. "Sono‐Controllable and ROS‐Sensitive CRISPR‐Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy." Advanced Materials (Weinheim) 33, no. 45 (2021): e2104641-n/a. https://doi.org/10.1002/adma.202104641.
MLA-Zitierstil (9. Ausg.)Pu, Yinying, et al. "Sono‐Controllable and ROS‐Sensitive CRISPR‐Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy." Advanced Materials (Weinheim), vol. 33, no. 45, 2021, pp. e2104641-n/a, https://doi.org/10.1002/adma.202104641.